Plunkett Research Online: Kun Run Biotechnology, Inc.

KUN RUN BIOTECHNOLOGY, INC. (KURU:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kun Run Biotechnology Inc through its subsidiary, Hainan Zhonghe Pharmaceutical Co., Ltd. is engaged in the development, manufacture, marketing and sale of prescription polypeptide drugs......



Kun Run Biotechnology, Inc.
Ticker: KURU
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 86 89866802207
Fax:
Address: Free Trade Zone
168 Nanhai Avenue
Haikou City, Hainan Province T3M 1C4 China

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Xiaoqun YeCEO
Xueyun CuiChairman of the Board/Director
See More
Kun Run Biotechnology Inc through its subsidiary, Hainan Zhonghe Pharmaceutical Co., Ltd. is engaged in the development, manufacture, marketing and sale of prescription polypeptide drugs......See More See More

Auditor: PKF
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: